Similarly, in a subgroup analysis of patients bearing intermediate cytogenetics and wt FLT3, 10/10 UD-HSCT showed a trend for better LFS without a survival advantage over auto-HSCT.
← all excerpts
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT.
1
—
—